Netherlands· NL-dba0b15b3f89
Anzupgo 20 mg/g crème
A delgocitinib product containing delgocitinib, registered in Netherlands by Leo Pharma A/S. The same ATC class is registered in 15 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Delgocitinib is registered in 15 of 19 countries.
Countries holding a registration under ATC D11AH11 (delgocitinib), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 10 of them publish a price we can compare per daily dose
Delgocitinib · ATC D11AH11
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- DELGOCITINIB
- Manufacturer
- Leo Pharma A/S
- Country
- Netherlands (NL)
- ATC code
- D11AH11
- ATC class
- Delgocitinib
- Defined daily dose
- 40 mg, T
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/24/1851
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Delgocitinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaANZUPGOLEO Pharma A/S, Ballerup
- NorwayAnzupgoLEO PHARMA A/S (Danmark)
- United StatesAnzupgoLEO Pharma, Inc
- FranceANZUPGO 20 mg/g, crèmeLEO PHARMA A/S (DANEMARK)
- SwitzerlandAnzupgo
- IcelandAnzupgoLEO Pharma A/S*
- PolandAnzupgoLEO Pharma A/S
- SwedenAnzupgo 20 mg/g KrämLEO Pharma A/S
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Anzupgo
- Iceland · Anzupgo
- Liechtenstein · Anzupgo
- Norway · Anzupgo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b905bca6-7507-4c43-bf21-07aeadc0719d GET /v1/drugs/b905bca6-7507-4c43-bf21-07aeadc0719d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Crème",
"route": "Cutaan gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/anzupgo-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Delgocitinib",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp131930",
"excipients": [
"BENZYLALCOHOL (E 1519)",
"BUTYLHYDROXYANISOL (E 320)",
"CETOSTEARYLALCOHOL",
"CITROENZUUR 1-WATER (E 330)",
"DINATRIUMEDETAAT 2-WATER",
"MACROGOLCETOSTEARYLETHER",
"PARAFFINE, VLOEIBAAR (E905)",
"WATER, GEZUIVERD",
"ZOUTZUUR (E 507)"
],
"substances": [
"DELGOCITINIB"
],
"leaflet_url": null,
"authorised_at": "2024/09/19",
"procedure_number": "EMEA/H/C/006109",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/24/1851",
"additional_monitoring": "Y"
}See everything about delgocitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.